Default company panoramic image

Waterlily Pharmaceuticals

Waterlily Pharmaceuticals exploit hypoxia-target imaging agents of MRI and PET for cancer diagnosis and prodrugs for cancer therapy.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Burlington, MA, USA
  • Currency USD

Company Summary

Start up company focus on the research and development for hypoxia-target cancer diagnosis and treatment.


  • Default avatar
    Xiaoshen Ji

    Working on hypoxia-target PET and MRI imaging agents for tumor diagnosis and hypoxia-target prodrugs for cancer therapy. Designed and synthesized series of 2-nitroimidazole derivative and F, Cu and Gd compounds for above use.